DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Phillips, David H.
MetadataShow full item record
AbstractBulky DNA adducts are biomarkers of exposure to aromatic compounds and of the ability of the individual to metabolically activate carcinogens and to repair DNA damage. Their ability to predict cancer onset is uncertain. We have performed a pooled analysis of three prospective studies on cancer risk in which bulky DNA adducts have been measured in blood samples collected from healthy subjects (N = 1947; average follow-up 51-137 months). In addition, we have performed a meta-analysis by identifying all articles on the same subject published up to the end of 2006, including case-control studies. In the pooled analysis, a weakly statistically significant increase in the risk of lung cancer was apparent (14% per unit standard deviation change in adduct levels, 95% confidence interval 1-28%; using the weighted mean difference method, 0.15 SD, units higher adducts in cases than in controls). The association was evident only in current smokers and was absent in former smokers. Also the meta-analysis, which included both lung and bladder cancers, showed a statistically significant association in current smokers, whereas the results in never smokers were equivocal; in former smokers, no association was detected. The results of our pooled and meta-analyses suggest that bulky DNA adducts are associated with lung cancer arising in current smokers after a follow-up of several years.
CitationDNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis. 2008, 29 (5):932-6 Carcinogenesis
SponsorsEuropean Union (FOOD-CT-2005-513943) (WP4-8) to Environmental Cancer Risk, nutrition and individual susceptibility Network of Excellence (EC CONTRACT Food-CT-2005-513943).
- DNA adducts and lung cancer risk: a prospective study.
- Authors: Peluso M, Munnia A, Hoek G, Krzyzanowski M, Veglia F, Airoldi L, Autrup H, Dunning A, Garte S, Hainaut P, Malaveille C, Gormally E, Matullo G, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Trichopoulos D, Kaladidi A, Palli D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Kumle M, Gonzalez CA, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Berglund G, Janzon L, Jarvholm B, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Vineis P
- Issue date: 2005 Sep 1
- Bulky DNA adducts and risk of cancer: a meta-analysis.
- Authors: Veglia F, Matullo G, Vineis P
- Issue date: 2003 Feb
- Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
- Authors: Li D, Firozi PF, Wang LE, Bosken CH, Spitz MR, Hong WK, Wei Q
- Issue date: 2001 Feb 15
- 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study.
- Authors: Airoldi L, Vineis P, Colombi A, Olgiati L, Dell'Osta C, Fanelli R, Manzi L, Veglia F, Autrup H, Dunning A, Garte S, Hainaut P, Hoek G, Krzyzanowski M, Malaveille C, Matullo G, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Peluso M, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Agudo A, Martinez C, Dorronsoro M, Barricarte A, Chirlaque MD, Quiros JR, Berglund G, Järvholm B, Hallmans G, Day NE, Allen N, Saracci R, Kaaks R, Riboli E
- Issue date: 2005 Sep
- A molecular epidemiological case-control study of lung cancer.
- Authors: Tang D, Santella RM, Blackwood AM, Young TL, Mayer J, Jaretzki A, Grantham S, Tsai WY, Perera FP
- Issue date: 1995 Jun